Siblings Books/Book Section [4/5] Conference Papers/Meeting Abstract [3/4] Patents [0/44] Collection Statistics Item counts issued in 3 years:2(2.00%) Items With Fulltext:97(97.00%) Download counts of the item Download times greater than 0:97(100.00%) Download times greater than 100:97(100.00%) Total Bitstream Download Counts:67232(94.66%) Last Update: 2024-12-01 10:01 Top Upload Loading... Top Download Loading... Recent Submissions Propagation and immunological chara... The uncoating of EV71 in mature lat... Polysorbasome: A colloidal vesicle ... Enhancing enterovirus A71 vaccine p... Degradable emulsion as vaccine adju... Development of a full-length cDNA-d... Immunogenicity of a novel tetravale... Mucosal delivery of a combination a... Immunological and biochemical chara... The successful induction of T-cell ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-100 of 100. (2 Page(s) Totally) << < 1 2  View [10|25|50] records per page

Date	Title	Relation
2012-07-23	The immunomodulatory activity of meningococcal lipoprotein Ag473 depends on the conformation made up of the lipid and protein moieties	PLoS ONE. 2012 Jul 23;7(7):Article number e40873.
2012-07	Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model	PLoS ONE. 2012 Jul;7(7):Article number e40970.
2012-06	Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles	PLoS ONE. 2012 Jun;7(6):Article number e39075.
2012-05	Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses	PLoS Neglected Tropical Diseases. 2012 May;6(5):Article number e1645.
2012-04	A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo	Journal of Immunotherapy. 2012 Apr;35(3):235-244.
2012-04	Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates	PLoS ONE. 2012 Apr;7(4):Article number e34834.
2012-01	Selection and characterization of vaccine strain for Enterovirus 71 vaccine development	Vaccine. 2012 Jan;30(4):703-711.
2012-01	Human SCARB2-Mediated entry and endocytosis of EV71	PLoS ONE. 2012 Jan;7(1):Article number e30507.
2011-10	Adaptation of high-growth influenza H5N1 vaccine virus in vero cells: Implications for pandemic preparedness	PLoS ONE. 2011 OCT;6(10):Article number e24057.
2011-09	Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process	Journal of Virological Methods. 2011 Sep;176(1-2):60-68.
2011-09	Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines	Vaccine. 2011 Sep;29(41):7163-7172.
2011-09	Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse	PLoS ONE. 2011 Sep;6(9):Article number e25500.
2011-08	Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo	Journal of Leukocyte Biology. 2011 Aug;90(2):323-332.
2011-08	A novel single-dose dengue subunit vaccine induces memory immune responses	PLoS ONE. 2011 Aug;6(8):Article number e23319.
2011-07	Rapid Isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis	Proteomics. 2011 Jul;11(13):2620-2627.
2011-06	T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer	Journal of Medical Virology. 2011 Jun;83(6):1023-1030.
2011-06	Identification and characterization of a cross-neutralization epitope of Enterovirus 71	Vaccine. 2011 Jun;29(26):4362-4372.
2011-05	Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system	PLoS ONE. 2011 May;6(5):Article number e20005.
2011-05	Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines	PLoS ONE. 2011 May;6(5):Article number e20052.
2011-05	Tonsillar CD4(+)FOXP3(+) T-regulatory cell dynamics in primary EBV infection	Immunologic Research. 2011 May;50(1):97-101.
2011-05	Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates	Journal of Virological Methods. 2011 May;173(2):189-195.
2011-04	Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes	Immunobiology. 2011 Apr;216(4):491-496.
2011-04	Expression of the sperm fibrous sheath protein CABYR in human cancers and identification of alpha-enolase as an interacting partner of CABYR-a	Oncology Reports. 2011 Apr;25(4):1169-1175.
2011-01	Production of inactivated influenza H5N1 vaccines from MDCK Cells in serum-free medium	PLoS ONE. 2011 Jan;6(1): Article number e14578.
2010-12	Identifying conserved DR1501-restricted CD4+ T cell epitopes in avian H5N1 hemagglutinin proteins	Viral Immunology. 2010 Dec;23(6):585-593.
2010-11	Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B	Vaccine. 2010 Nov;28(51):8175-8182.
2010-09	T-cell response to human papillomavirus type 58 L1, E6 and E7 peptides in women with cleared infection, cervical intraepithelial neoplasia and invasive cancer	Clinical and Vaccine Immunology. 2010 Sep;17(19):1315-1321.
2010-08	Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice	PLoS ONE. 2010 Aug;5(8):Article number e12279.
2010-07	A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide	Molecular Immunology. 2010 Jul;47(11-12):2015-2021.
2010-06	IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth	Immunobiology. 2010 Jun;215(6):486-491.
2009-11-01	Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization	Cancer Biology and Therapy. 2009 Nov 1;8(21):2025-2032.
2009-11	以佐劑對抗流感	科學人. 2009 Nov(93):80-81.
2009-10	Characterization and emulsifying properties of block copolymers prepared from lactic acid and poly(ethylene glycol)	Journal of Applied Polymer Science. 2009 Oct;114(1):509-516.
2009-09-04	Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses	Vaccine. 2009 Sep 4;27(40):5460-5471.
2009-08	Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone)	Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009 Aug;90(2):832-841.
2009-08	Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant	Pharmaceutical Research. 2009 Aug;26(8):1856-1862.
2009-05-22	Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus	Biochemical and Biophysical Research Communications. 2009 May 22;383(1):27-31.
2009-05-15	Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein	Biochemical and Biophysical Research Communications. 2009 May 15;382(4):691-696.
2009-05	Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine	Microbes and Infection. 2009 May;11(6-7):654-660.
2009-02-25	A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design	Vaccine. 2009 Feb 25;27(9):1400-1409.
2009-02	A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity	Microbes and Infection. 2009 Feb;11(2):288-295.
2008-10	Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines	Vaccine. 2008 Oct;26(45):5736-5740.
2008-09	DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans	Biochemical and Biophysical Research Communications. 2008 Sep;373(4):561-566.
2008	The Asian Vaccine Industry: Opportunities and challenges	Pharma Focus Asia. 2008;6:42-46.
2007-07-06	Identification of synthetic vaccine candidates against SARS CoV infection	Biochemical and Biophysical Research Communications. 2007 Jul;358(3):716-721.
2007-06	The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus	Review of Diabetic Studies. 2007 Jun;4(2):68-76.
2007-03	The development and application of HLA tetramers in the detection, characterization and therapy of type 1 diabetes mellitus	Review of Diabetic Studies. 2007 Mar;4(1):56-61.
2006-04-12	Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates	Vaccine. 2006 Apr;24(16):3100-3108.
2006-02-20	Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development	Vaccine. 2006 Feb;24(8):1132-1141.
2005-10	Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)	Journal of Biomedical Science. 2005 Oct;12(5):711-727.

Showing items 51-100 of 100. (2 Page(s) Totally) << < 1 2  View [10|25|50] records per page